TMO icon

Thermo Fisher Scientific

497.60 USD
-2.56
0.51%
At close Mar 31, 4:00 PM EDT
After hours
480.88
-16.72
3.36%
1 day
-0.51%
5 days
-4.58%
1 month
-5.93%
3 months
-4.35%
6 months
-19.56%
Year to date
-4.78%
1 year
-13.83%
5 years
75.46%
10 years
270.40%
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

36% more first-time investments, than exits

New positions opened: 272 | Existing positions closed: 200

1% more funds holding

Funds holding: 2,529 [Q3] → 2,544 (+15) [Q4]

0.28% less ownership

Funds ownership: 88.63% [Q3] → 88.35% (-0.28%) [Q4]

15% less capital invested

Capital invested by funds: $208B [Q3] → $177B (-$30.9B) [Q4]

19% less repeat investments, than reductions

Existing positions increased: 869 | Existing positions reduced: 1,069

27% less call options, than puts

Call options by funds: $1.06B | Put options by funds: $1.44B

38% less funds holding in top 10

Funds holding in top 10: 116 [Q3] → 72 (-44) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$570
15%
upside
Avg. target
$660
33%
upside
High target
$715
44%
upside

6 analyst ratings

positive
67%
neutral
33%
negative
0%
Citigroup
Patrick Donnelly
23% 1-year accuracy
7 / 31 met price target
15%upside
$570
Neutral
Maintained
4 Mar 2025
Scotiabank
Sung Ji Nam
17% 1-year accuracy
4 / 24 met price target
31%upside
$650
Sector Perform
Maintained
3 Feb 2025
Raymond James
Andrew Cooper
6% 1-year accuracy
1 / 16 met price target
34%upside
$667
Outperform
Reiterated
3 Feb 2025
UBS
Dan Leonard
14% 1-year accuracy
1 / 7 met price target
44%upside
$715
Buy
Maintained
31 Jan 2025
Wells Fargo
Brandon Couillard
19% 1-year accuracy
4 / 21 met price target
37%upside
$680
Overweight
Maintained
31 Jan 2025

Financial journalist opinion

Based on 11 articles about TMO published over the past 30 days

Neutral
Business Wire
15 hours ago
Thermo Fisher Scientific Launches First More Sustainable Large-Capacity and Superspeed Centrifuges with Next-Generation Natural Refrigerant Cooling System
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced today new lines of floor-model centrifuges to provide more sustainable solutions without compromising performance and sample security. The Thermo Scientific™ Cryofuge™, Thermo Scientific™ BIOS and Thermo Scientific™ LYNX centrifuges are the first floor-model centrifuges that feature natural refrigerant cooling systems compliant with European Union (E.U.) and U.S. Environmental Protect.
Thermo Fisher Scientific Launches First More Sustainable Large-Capacity and Superspeed Centrifuges with Next-Generation Natural Refrigerant Cooling System
Positive
Zacks Investment Research
3 days ago
Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock
TMO and CZ Imaging Institute to collaborate on further understanding of human cells.
Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock
Neutral
GlobeNewsWire
3 days ago
Biohazard Bags Report 2025-2030 Featuring Thermo Fisher Scientific, Bel-Art, International Plastics, Cole-Parmer, Medegen, Tufpak, Capitol Scientific, Abdos Life Science, Tilak Polypack, Desco Medical
Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Biohazard Bags Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.
Biohazard Bags Report 2025-2030 Featuring Thermo Fisher Scientific, Bel-Art, International Plastics, Cole-Parmer, Medegen, Tufpak, Capitol Scientific, Abdos Life Science, Tilak Polypack, Desco Medical
Neutral
Business Wire
4 days ago
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). This agreement aims to develop new technologies to enable researchers to better visualize human cells, significantly advancing scientific research and discovery. Cryo-electron microscopy (cryo-EM) is an essential tool in disease research and creating lifesaving.
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
Positive
Zacks Investment Research
1 week ago
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab
Thermo Fisher introduces the Vulcan Automated Lab to transform semiconductor analysis.
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab
Neutral
Business Wire
1 week ago
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the launch of the Thermo Scientific Vulcan™ Automated Lab, a groundbreaking solution designed to drive a new era of process development and control in semiconductor manufacturing. The seamlessly integrated system is designed to enhance productivity, increase yield and reduce operating costs for semiconductor manufacturers. The rapid evolution and min.
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis
Positive
Seeking Alpha
3 weeks ago
Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks
Barron's New-Year (NY) Roundtable (RT) selections published in three issues 1/13-27/2025, listed 34 dividend picks as the best of 2025. Analysts predict top picks like AdvanSix, Applied Materials, and Salesforce could net significant returns, with an average gain estimate of 28.85%. Two standout "safer" stocks, AT&T and Annaly Capital, meet the dogcatcher ideal, offering high yields relative to their prices.
Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks
Positive
Seeking Alpha
3 weeks ago
Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences
Thermo Fisher Scientific's Q4'24 and FY'24 results exceeded expectations, with revenue and profitability growing, positioning it for a potential 12% IRR long-term. Strong capital allocation, including $4.6 billion returned to shareholders and strategic acquisitions, supports Thermo Fisher's growth and undervalued stock potential. Despite weak guidance, Thermo Fisher's leadership in life sciences and pharma, along with expected 11% CAGR earnings growth, indicates a solid long-term outlook.
Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences
Positive
24/7 Wall Street
3 weeks ago
Billionaire Investor Buys Stocks Despite Trump's ‘Unconventional Approach'
Daniel Loeb is a brilliant billionaire investor who's invested in all sorts of market environments.
Billionaire Investor Buys Stocks Despite Trump's ‘Unconventional Approach'
Positive
The Motley Fool
3 weeks ago
3 Dividend Stocks That Recently Raised Payouts More Than 10%
If you're buying stocks for their dividend payments, it's important to focus on companies that also increase those payments. This can enable you to earn rising dividend income that offsets the effects of inflation.
3 Dividend Stocks That Recently Raised Payouts More Than 10%
Charts implemented using Lightweight Charts™